(Reuters) - U.S. drugmaker Vivus Inc, locked in a proxy battle with top investor First Manhattan Co, said FMC's advisers had made false statements to its shareholders and that it would delay its annual meeting by three days to allow FMC to mak...
Source: http://health.yahoo.net/news/s/nm/vivus-says-victim-of-false-statements-delays-shareholder-meet
click here found here more
No comments:
Post a Comment
Note: only a member of this blog may post a comment.